Momenta Pharmaceuticals, Inc. (MNTA)

[Regulardoc]

Thanks. The article is quite enlightening.

So here is another question, and for the record, I am not into conspiracy theory.

Firstly, have any other products from this PFE facility been delayed for facility compliance concerns? This of course assumes that Glatopa is otherwise ready for approval.

And secondly, given that PFE is Synthon's exclusive partner for commercialization of Synthon's glatiramer acetate in the US, any reason to believe that PFE is slow playing any needed correction action?